Efficacy and Safety of Switching from Ranibizumab to Brolucizumab in Age-Related Macular Degeneration: Multicenter Real-World Outcomes
在年龄相关性黄斑变性中,从雷珠单抗转换为布罗鲁珠单抗的疗效和安全性:多中心真实世界结果
期刊:
影响因子:
doi:10.2147/OPTH.S543921
Hejsek, Libor; Hrevuš, Michal; Burova, Maria; Beran, David; Cyžová, Zuzana; Penčák, Martin; Pařilová, Tereza; Liláková, Dana; Veith, Miroslav